University of Utah Hospital

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology

Retrieved on: 
Tuesday, January 23, 2024

ATLANTA, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative therapeutic and diagnostic products, today announced that it has activated enrollment for its pivotal FemBloc trial at another academic site, University of Utah Hospital in Salt Lake City, Utah. The FemBloc Intratubal Occlusion for TranscervicAL Permanent Birth Control (the “FINALE” trial) is being conducted to investigate the safety and efficacy of its investigational permanent birth control candidate, FemBloc®. The FDA-approved, multi-center trial is designed to help women seeking permanent birth control, for whom elective surgery currently remains the only option.

Key Points: 
  • The FemBloc Intratubal Occlusion for TranscervicAL Permanent Birth Control (the “FINALE” trial) is being conducted to investigate the safety and efficacy of its investigational permanent birth control candidate, FemBloc®.
  • The FDA-approved, multi-center trial is designed to help women seeking permanent birth control, for whom elective surgery currently remains the only option.
  • Gawron’s consistent involvement demonstrates support for FemBloc and the importance that it may hold in providing optionality to women seeking additional and improved birth control options."
  • An in-office option like FemBloc has the opportunity to change how we deliver care to women when they no longer wish to be at risk of pregnancy but no longer want exposure to hormones or implants or surgery.”

David Entwistle, President and CEO of Stanford Health Care, Joins Redesign Health Board of Directors

Retrieved on: 
Thursday, August 17, 2023

Today Redesign Health, a healthcare innovation company, welcomes David Entwistle to its board of directors.

Key Points: 
  • Today Redesign Health, a healthcare innovation company, welcomes David Entwistle to its board of directors.
  • As the president and CEO of Stanford Health Care, Entwistle brings unparalleled healthcare and leadership expertise to the board.
  • His appointment comes as Redesign Health has reached a notable milestone of successfully creating over 50 companies since 2018.
  • "David is an uncommonly effective leader, who understands what it takes to make an impact in healthcare,” said Brett Shaheen, CEO of Redesign Health.

Volpara highlights cancer risk assessment, breast density assessment and mammography quality software at SBI 2023

Retrieved on: 
Wednesday, May 3, 2023

LYNNWOOD, Wash., May 3, 2023 /PRNewswire/ -- Volpara Health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection of cancer, is attending the 2023 Society of Breast Imaging annual symposium, May 4-7 in Maryland. The company will be showcasing how breast care professionals can use its software to quantify cancer risk and provide personalized care planning as well as help improve efficiency, accuracy and quality of the whole mammography process.

Key Points: 
  • The company will be showcasing how breast care professionals can use its software to quantify cancer risk and provide personalized care planning as well as help improve efficiency, accuracy and quality of the whole mammography process.
  • Using Volpara Risk Pathways™ healthcare providers can use their existing EHR such as Epic® or mammography system workflows like Volpara's Patient Hub™ to assess a patient's a risk of developing multiple forms of cancer.
  • This broad cancer risk assessment capability adds value to the entire health system by capitalizing on the opportunity of mammography appointments to personalize and coordinate care without disrupting workflow.
  • To learn more about cancer risk assessment, breast density assessment and education, or image quality, visit Volpara at SBI booth #307.

IOTAMOTION SURPASSES 125 USE CASES IN LIMITED MARKET RELEASE WITH EXPANSION OF CENTERS TO TAKE PLACE IN 2023

Retrieved on: 
Wednesday, February 1, 2023

Gaining authorization by FDA via a De Novo pathway in Q4 2021, iotaMotion began the Limited Market Release (LMR) of iotaSOFT in Q3 of 2022 at select centers across the country.

Key Points: 
  • Gaining authorization by FDA via a De Novo pathway in Q4 2021, iotaMotion began the Limited Market Release (LMR) of iotaSOFT in Q3 of 2022 at select centers across the country.
  • iotaMotion has leveraged this early release to garner initial feedback from surgeon partners, expand training, and build up internal support infrastructure.
  • With the LMR coming to a close, iotaMotion will continue to partner with these initial centers and expand into additional hospitals and ASC's in 2023.
  • iotaSOFT will expand to many top cochlear implant centers throughout the country as part of an expanded, controlled market release.

NRC Health Unveils Winners of 2022 Annual Awards Programs

Retrieved on: 
Tuesday, August 16, 2022

LINCOLN, Neb., Aug. 16, 2022 (GLOBE NEWSWIRE) -- NRC Health, the leading partner in building Human Understanding through personalized healthcare solutions and data-driven insights, today announced the 2022 winners of its annual awards programs, the Consumer Loyalty Awards and the Excellence in Patient Experience Awards, formerly known as the Excellence Awards. NRC Health’s loyalty-based hospital ranking recognizes the top 100 healthcare facilities, including the top 10 Best-In-Class winners, that are working to cultivate and maintain long-lasting loyalty among their patient populations. This year’s Excellence in Patient Experience honorees have been recognized for their efforts to consistently deliver outstanding patient experiences across the care continuum.

Key Points: 
  • LINCOLN, Neb., Aug. 16, 2022 (GLOBE NEWSWIRE) -- NRC Health , the leading partner in building Human Understanding through personalized healthcare solutions and data-driven insights, today announced the 2022 winners of its annual awards programs, the Consumer Loyalty Awards and the Excellence in Patient Experience Awards , formerly known as the Excellence Awards.
  • Winners of the NRC Health 2022 Excellence in Patient Experience Awards accomplished just that.
  • This years winners include Hawaii Pacific Health, Lehigh Valley Health Network, Mercy Health, and Northwest Community Healthcare as well as repeat winners from last year, Wabash General Hospital, Community Hospital of the Monterey Peninsula, Scottish Rite for Children and Tyron Medical Partners.
  • To see if your local hospital is a 2022 honoree, see the full lists of winning organizations for both the 2022 Consumer Loyalty Awards and the 2022 Excellence in Patient Experience Awards .

Intermountain Healthcare, DonorConnect, and InVita Healthcare Technologies launch iReferral Interoperability to Save and Heal More Lives

Retrieved on: 
Tuesday, July 19, 2022

SALT LAKE CITY, July 19, 2022 /PRNewswire/ -- Intermountain Healthcare, DonorConnect, and InVita Healthcare Technologies announce the launch of iReferral℠ interoperability in Utah and Idaho to streamline the critical first step in the organ, tissue and eye donation-transplantation process. iReferral℠ automates the identification and referral of potential donors and helps to liberate hospital and donation resources while strengthening donation and transplant activity.

Key Points: 
  • SALT LAKE CITY, July 19, 2022 /PRNewswire/ -- Intermountain Healthcare, DonorConnect, and InVita Healthcare Technologies announce the launch of iReferral interoperability in Utah and Idaho to streamline the critical first step in the organ, tissue and eye donation-transplantation process.
  • "Collaborating and improving our workflow will also result in more donors, especially for those waiting for a critical life-saving donor organ."
  • Utilizing targeted algorithmic clinical triggers and secure interoperability, iReferral eliminates the need for manual, phone-based referral processes.
  • Wade Liu, Vice President of Product for InVita Healthcare Technologies' Transplant division said, "iReferral represents a unique win and step forward for all involved in the donation-transplantation ecosystem.

SelectHealth Announces the Addition of University of Utah Facilities and Providers to its Medicare Advantage Network

Retrieved on: 
Thursday, May 5, 2022

Salt Lake City, UT, May 05, 2022 (GLOBE NEWSWIRE) -- To help meet the growing need for healthcare services for Medicare beneficiaries in Utah, SelectHealth and University of Utah Health announced today an agreement in which SelectHealth is adding full access to University of Utah hospitals, clinics, and providers for its Medicare Advantage network.

Key Points: 
  • Salt Lake City, UT, May 05, 2022 (GLOBE NEWSWIRE) -- To help meet the growing need for healthcare services for Medicare beneficiaries in Utah, SelectHealth and University of Utah Health announced today an agreement in which SelectHealth is adding full access to University of Utah hospitals, clinics, and providers for its Medicare Advantage network.
  • The agreement is effective July 1, 2022, and creates access to services and facilities throughout the University of Utah Health system.
  • We are excited about this new partnership with SelectHealth, said Michael Good, M.D., CEO of University of Utah Health.
  • To review a list of facilities and providers within the University of Utah Health system, visit healthcare.utah.edu .

First Mom and Baby In-Utero Fetal Surgery in Utah Reunited with Intermountain Primary Children’s and U of U Health Medical Team

Retrieved on: 
Wednesday, April 13, 2022

The complex, often life-saving surgery is available at only a few hospitals nationwide and now includes the Utah Fetal Center.

Key Points: 
  • The complex, often life-saving surgery is available at only a few hospitals nationwide and now includes the Utah Fetal Center.
  • The surgery is so complex that only a handful of hospitals in the country can perform it, said Stephen Fenton, MD, a pediatric surgeon with University of Utah Health and Intermountain Primary Childrens Hospital and director of Utah Fetal Center.
  • The fetal surgery is made possible through a partnership between University of Utah Health and Intermountain Primary Childrens Hospital.
  • Fetal surgery is part of Intermountain Healthcares Primary Promise to create the nations model health system for children .

Lucidpress Announces Addition of Wes Novack and Brandon Moss to Leadership Team

Retrieved on: 
Thursday, September 30, 2021

SALT LAKE CITY, Sept. 30, 2021 /PRNewswire/ --Lucidpress, the leading design and brand templating software provider for businesses, announced today that Wes Novack and Brandon Moss have joined the company's leadership team.

Key Points: 
  • SALT LAKE CITY, Sept. 30, 2021 /PRNewswire/ --Lucidpress, the leading design and brand templating software provider for businesses, announced today that Wes Novack and Brandon Moss have joined the company's leadership team.
  • Adding them to our leadership team is a testament to how Lucidpress is maturing both as a product and as a company," said Owen Fuller, CEO of Lucidpress.
  • "Already, Brandon is laying the foundation for some big product initiatives, while Wes is helping us scale our engineering organization.
  • He brings extensive product management experience to the Lucidpress team, having worked at tech companies Podium, Domo and DealerSocket.

Dan Lundergan Named CEO of University of Utah Health Hospitals and Clinics

Retrieved on: 
Thursday, September 2, 2021

SALT LAKE CITY, Sept. 2, 2021 /PRNewswire/ -- Dan Lundergan, MHA, Chief Operating Officer at University of Utah Health Hospitals and Clinics, has been appointed to the role of Chief Executive Officer.

Key Points: 
  • SALT LAKE CITY, Sept. 2, 2021 /PRNewswire/ -- Dan Lundergan, MHA, Chief Operating Officer at University of Utah Health Hospitals and Clinics, has been appointed to the role of Chief Executive Officer.
  • Lundergan will oversee U of U Health's five hospitals and 12 community clinics as well as the nearly 14,000 employees who work in the clinical system.
  • Known for his unrelenting focus on delivering world-class health care to patients at U of U Health, Lundergan has overseen the organization while it has been recognized for major accolades.
  • Lundergan received a bachelor's degree in economics at the University of Utah and a Master of Healthcare Administration (MHA) at the University of Minnesota.